Roswell Park Cancer Institute Center Support Grant

罗斯威尔帕克癌症研究所中心支持补助金

• 批准号: 7933236
• 负责人: DONALD L TRUMP
• 金额: $ 130.03万
• 依托单位: ROSWELL PARK CANCER INSTITUTE CORP
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-30 至 2012-09-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7933236
• 关键词: Roswell; Park; Cancer; Institute; Center

DESCRIPTION (provided by applicant): The Roswell Park Cancer Institute (RPCI) has been continuously recognized as a Comprehensive Cancer Center since the NCI designation of such centers in 1974 and is now requesting continued federal support for the next five years. A free-standing research, education and clinical cancer care Institute, RPCI occupies a 27 acre campus near downtown Buffalo and has expanded to nearly 1.6M gsf of clinical and research space, a 16% increase since the last review period. RPCI serves a population base of ~1.5M in Western New York where the RPCI tumor registry is recording more than 3,400 new cancer patients per year. RPCI has strong collaborations with the University of Buffalo and the Hauptman-Woodward Institute for Structural Biology, but is a fully independent entity with Dr. Donald Trump, CCSG PI and RPCI President/CEO, answering only to the RPCI Board of Directors. Since the last competitive renewal, the RPCI has grown significantly as demonstrated by: 1) the recruitment of over 100 new faculty clinicians and researchers of which 43 are new CCSG members; 2) a 74% increase in total NCI funding and a 44% increase in total peer-reviewed funding; 3) a 73% increase in accrual to investigator-initiated, interventional clinical trials and a 44% increase to accrual in all interventional trials; 4) the addition of 4 new shared resources with an institutional investment of over $2.0 M and (5) the opening of a new, 177,000 gsf, state-of-the-art research building housing Program member laboratories and Shared Resources. With the growth in faculty has also come the recruitment of three Senior Leaders. In addition, a director for the newly created RPCI Office of Cancer Health Disparities Research has also been recruited. As part of the scientific growth within RPCI, a new disease-specific Research Program, the Prostate Program, has been added in this renewal bringing RPCI to a total of six Scientific Programs that also include Cancer Prevention & Population Sciences, Cell Stress & Biophysical Therapies, Genetics, Molecular Targets & Experimental Therapeutics and Tumor Immunology & Immunotherapy. With strong leadership and institutional commitment, RPCI will continue to focus on recruiting talented investigators to further expand research efforts targeting areas in genetics, investigational imaging and cancer health disparities.

描述(申请人提供)：罗斯韦尔公园癌症研究所(RPCI)自1974年被NCI指定为综合癌症中心以来，一直被公认为综合癌症中心，目前正在请求联邦政府在未来五年继续提供支持。RPCI是一家独立的研究、教育和临床癌症护理研究所，占地27英亩，位于布法罗市中心附近，临床和研究空间已扩大到近160万GSF，比上一次审查期间增加了16%。 RPCI为纽约西部约150万人口提供服务，那里的RPCI肿瘤登记每年记录了3400多名新的癌症患者。RPCI与布法罗大学和Hauptman-Woodward结构生物学研究所有着密切的合作，但它是一个完全独立的实体，由Donald Trump博士、CCSG Pi和RPCI总裁/首席执行官组成，只向RPCI董事会负责。 自上次竞争更新以来，RPCI显著增长，表现为：1)招募了100多名新的教职临床医生和研究人员，其中43人是CCSG的新成员；2)NCI资金总额增加了74%，同行评审资金总额增加了44%；3)研究人员发起的干预性临床试验的收益增加了73%，所有干预试验的收益增加了44%；4)增加4个新的共享资源，机构投资超过200万美元；(5)开设一座新的、17.7万GSF的最先进的研究大楼，容纳计划成员实验室和共享资源。随着教职员工的增加，还招聘了三名高级领导人。此外，还为新成立的RPCI癌症健康差异研究办公室招聘了一名主任。作为RPCI科学发展的一部分，在这次更新中增加了一个新的针对疾病的研究计划--前列腺计划，使RPCI六个科学计划包括癌症预防和人口科学、细胞应激和生物物理治疗、遗传学、分子靶标和实验治疗以及肿瘤免疫学和免疫治疗。 凭借强大的领导力和机构承诺，RPCI将继续专注于招聘有才华的研究人员，以进一步扩大针对遗传学、调查成像和癌症健康差异领域的研究努力。